drugset / Trial / NCT01898273
Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
NaSingle-groupOpen-labelDiagnostic
Summary
The primary objective of this trial is to determine the optimal dose and imaging time point(s) of I-124-CLR1404 in subjects with newly diagnosed and recurrent glioma to be used in future trials.
Timeline
- Start
- 2014-02
- Primary completion
- 2015-09
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | I-124-CLR1404 | Unknown | — | Intravenous |